|Articles|April 19, 2021

COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 19, 2021

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

How many people in the US have been vaccinated against COVID-19?

According to the US Centers for Disease Control and Prevention, as of today, April 19, 2021, at 4:42 PM, EDT:

• 39.9% of total US population have received at least 1 dose
• 25.7% of total US population are fully vaccinated

The 5 states with the highest percentage of population fully vaccinated are:

1. Maine: 33.3%
2. New Mexico: 32.6%
3. Alaska: 32.2%
4. Connecticut: 32.2%
5. Rhode Island: 31.9%

How many cases of COVID-19 have been confirmed in the US?

According to the Johns Hopkins COVID-19 interactive map, as of today, April 19, 2021 at 9:20 AM, EDT, there have been:

• 31 670 846 confirmed cases
• 567 216 deaths

The 5 states with the highest total confirmed cases are:

1. California: 3 718 210
2. Texas: 2 850 668
3. Florida: 2 168 901
4. New York: 1 998 912
5. Illinois: 1 302 134

Deaths: California has the most deaths due to COVID-19 with 61 033 reported fatalities, followed by New York with 51 579, and Texas with 49 595.

How many cases of COVID-19 have been confirmed globally?

Globally, there have been 141 525 400 confirmed cases, 3 022 126 deaths, and 80 893 313 recoveries.

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Related to this article

September 3rd, 2026

FDA Approves Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for 2026-27 Season

FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.

September 2nd, 2026

Independent Review Supports Respiratory Virus Immunizations for 2026-27 Season

A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.

October 6th, 2026

9 Drugs Approved for Primary Care: Q3 2026

Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.

August 31st, 2026

FDA Approves Bixlenvo for HIV-1 Switch Therapy in Virologically Suppressed Adults

FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.

August 26th, 2026

FDA Expands Dolutegravir Approval to Infants With HIV-1 Weighing at Least 2 kg

FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.

October 12th, 2026

Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions

Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.

October 9th, 2026

FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia

FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.

October 8th, 2026

Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones

The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.